HomeMWG • FRA
InMed Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.26M | 7.59% |
Operating expense | 2.29M | 9.84% |
Net income | -2.12M | -23.10% |
Net profit margin | -168.12 | -14.42% |
Earnings per share | — | — |
EBITDA | -2.06M | -18.47% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.72M | -38.24% |
Total assets | 9.28M | -30.53% |
Total liabilities | 2.26M | 0.19% |
Total equity | 7.02M | — |
Shares outstanding | 1.21M | — |
Price to book | 0.39 | — |
Return on assets | -59.48% | — |
Return on capital | -70.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.12M | -23.10% |
Cash from operations | -1.66M | 14.21% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 2.92M | — |
Net change in cash | 1.26M | 165.16% |
Free cash flow | -793.31K | 37.91% |
Previous close
€2.26
Day range
€2.28 - €2.28
Year range
€1.63 - €8.10
Market cap
2.96M USD
Avg Volume
89.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1981
Headquarters
Website
Employees
13
